SUSAN STEELE: Open Payments
NPI 1265483721 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 16 payments from 8 companies in 2025. Trend: 2023 $547 · 2024 $199 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Medtronic, Inc. | 1 | $36 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Novo Nordisk Inc | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: CAMZYOS, LEQVIO, ELIQUIS, SYMPLICITY G3, LifeVest, Wegovy, ONPATTRO, Kerendia.
Industry payments across MI — which companies pay providers there.
